Gliadin Nanoparticles Containing Doxorubicin Hydrochloride: Characterization and Cytotoxicity

• Main Authors: Silvia Voci (Author), Agnese Gagliardi (Author), Nicola Ambrosio (Author), Maria Cristina Salvatici (Author), Massimo Fresta (Author), Donato Cosco (Author)
• Format: Book
• Published: MDPI AG, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Doxorubicin hydrochloride (DOX) is a well-known antitumor drug used as first line treatment for many types of malignancies. Despite its clinical relevance, the administration of the compound is negatively affected by dose-dependent off-target toxicity phenomena. Nanotechnology has helped to overcome...